GB1557331A - Pharmaceutical compositions containing an ergot alkaloid and heparing - Google Patents

Pharmaceutical compositions containing an ergot alkaloid and heparing

Info

Publication number
GB1557331A
GB1557331A GB49835/76A GB4983576A GB1557331A GB 1557331 A GB1557331 A GB 1557331A GB 49835/76 A GB49835/76 A GB 49835/76A GB 4983576 A GB4983576 A GB 4983576A GB 1557331 A GB1557331 A GB 1557331A
Authority
GB
United Kingdom
Prior art keywords
heparing
pharmaceutical compositions
compositions containing
ergot alkaloid
ergot
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB49835/76A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2554533A external-priority patent/DE2554533C3/en
Priority claimed from DE19762625403 external-priority patent/DE2625403A1/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB1557331A publication Critical patent/GB1557331A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Electronic Switches (AREA)
GB49835/76A 1975-12-04 1976-11-30 Pharmaceutical compositions containing an ergot alkaloid and heparing Expired GB1557331A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2554533A DE2554533C3 (en) 1975-12-04 1975-12-04 Use of dihydroergotamine and heparin
DE19762625403 DE2625403A1 (en) 1976-06-05 1976-06-05 Antithrombotic association of medicaments - contains heparin and an ergoline-(8)-carboxylic acid peptidic amide esp. dihydroergotamine opt. with polyvinyl pyrrolidone

Publications (1)

Publication Number Publication Date
GB1557331A true GB1557331A (en) 1979-12-05

Family

ID=25769698

Family Applications (1)

Application Number Title Priority Date Filing Date
GB49835/76A Expired GB1557331A (en) 1975-12-04 1976-11-30 Pharmaceutical compositions containing an ergot alkaloid and heparing

Country Status (17)

Country Link
JP (1) JPS5270031A (en)
AU (1) AU512782B2 (en)
CS (1) CS216164B2 (en)
ES (1) ES453869A1 (en)
FR (1) FR2333513A1 (en)
GB (1) GB1557331A (en)
HK (1) HK3083A (en)
IE (1) IE44359B1 (en)
IL (1) IL51043A (en)
IT (1) IT7827782A0 (en)
MY (1) MY8400064A (en)
NL (1) NL172401C (en)
NZ (1) NZ182790A (en)
PH (1) PH12759A (en)
PT (1) PT65919B (en)
SE (1) SE441142B (en)
SG (1) SG63482G (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2131691A (en) * 1982-12-10 1984-06-27 Sandoz Ltd Pharmaceutical compositions comprising hydrogenated ergot alkaloids and heparin

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809618A1 (en) * 1978-03-06 1979-09-20 Sandoz Ag NEW THERAPEUTIC PREPARATION AND METHOD FOR THE PRODUCTION THEREOF

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2131691A (en) * 1982-12-10 1984-06-27 Sandoz Ltd Pharmaceutical compositions comprising hydrogenated ergot alkaloids and heparin

Also Published As

Publication number Publication date
NL172401C (en) 1983-09-01
CS216164B2 (en) 1982-10-29
IE44359L (en) 1977-06-04
HK3083A (en) 1983-01-20
ES453869A1 (en) 1978-01-16
NL172401B (en) 1983-04-05
MY8400064A (en) 1984-12-31
NL7613316A (en) 1977-06-07
JPS5270031A (en) 1977-06-10
AU2024976A (en) 1978-06-08
AU512782B2 (en) 1980-10-30
PT65919A (en) 1977-01-01
SE7613252L (en) 1977-06-05
FR2333513B1 (en) 1980-03-28
NZ182790A (en) 1979-03-16
PT65919B (en) 1978-07-05
SE441142B (en) 1985-09-16
SG63482G (en) 1983-09-09
FR2333513A1 (en) 1977-07-01
IT7827782A0 (en) 1978-09-18
IE44359B1 (en) 1981-11-04
PH12759A (en) 1979-08-09
IL51043A0 (en) 1977-02-28
IL51043A (en) 1980-02-29

Similar Documents

Publication Publication Date Title
IL53419A0 (en) Pharmaceutical compositions containing certain ergot peptide alkaloids
GB1518444A (en) N-phenyl-imidazolidine derivatives processes for preparing them and pharmaceutical compositions containing them
ZA802620B (en) Steroid alkaloids and pharmaceutical compositions containing them
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
IL51133A0 (en) New ergoline derivatives their production and pharmaceutical compositions containing them
AU508628B2 (en) Ergot alkaloid compositions
ZA763917B (en) Pharmaceutical compositions and compounds
NZ182665A (en) Amine derivatives and pharmaceutical compositions
NZ182190A (en) Clavulanic acid derivatives and pharmaceutical compositions
GB1518041A (en) Oxadiazolinone derivatives and compositions containing them
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
IL48453A0 (en) Novel quinuclidine derivatives and pharmaceutical compositions containing them
IL50355A0 (en) New noroxymorphone derivatives their preparation and pharmaceutical compositions containing them
NZ181972A (en) N-aryl-n-(4-piperidyl)-arylacetamide derivatives and pharmaceutical compositions
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
NZ181168A (en) 3-sulphamyl benzylamine derivatives and pharmaceutical compositions intermidiates
NZ181727A (en) Pyrroline-2-one derivatives and pharmaceutical compositions
NZ181401A (en) 2-benzopyranone derivatives and pharmaceutical compositions
IL49668A0 (en) Stable solutions of ergot alkaloids,their preparation and pharmaceutical compositions comprising them
GB1557331A (en) Pharmaceutical compositions containing an ergot alkaloid and heparing
NZ181146A (en) Benzocycloheptathiophene derivatives and pharmaceutical compositions

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
429A Application made for amendment of specification (sect. 29/1949)
429H Application (made) for amendment of specification now open to opposition (sect. 29/1949)
429D Case decided by the comptroller ** specification amended (sect. 29/1949)
SPA Amended specification published
704A Declaration that licence is not available as of right for an excepted use (par. 4a/1977)
PCNP Patent ceased through non-payment of renewal fee